Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Oramed Pharmaceuticals Inc (NASDAQ: ORMP)

 
ORMP Technical Analysis
5
As on 9th Jun 2023 ORMP STOCK Price closed @ 3.87 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.02 & Strong Sell for SHORT-TERM with Stoploss of 11.22 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ORMPSTOCK Price

Open 4.00 Change Price %
High 4.07 1 Day -0.14 -3.49
Low 3.85 1 Week -0.17 -4.21
Close 3.87 1 Month 1.62 72.00
Volume 270068 1 Year -11.69 -75.13
52 Week High 15.56 | 52 Week Low 1.93
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ORMP
Daily Charts		 ORMP
Intraday Charts		 Whats New @
Bazaartrend		 ORMP
Free Analysis
 
ORMP Important Levels Intraday
RESISTANCE4.29
RESISTANCE4.16
RESISTANCE4.07
RESISTANCE3.99
SUPPORT3.75
SUPPORT3.67
SUPPORT3.58
SUPPORT3.45
 
ORMP Forecast May 2024
Share
4th UP Forecast14.04
3rd UP Forecast10.78
2nd UP Forecast8.76
1st UP Forecast6.75
1st DOWN Forecast0.99
2nd DOWN Forecast-1.02
3rd DOWN Forecast-3.04
4th DOWN Forecast-6.3
 
ORMP Weekly Forecast
4th UP Forecast10.29
3rd UP Forecast8.23
2nd UP Forecast6.96
1st UP Forecast5.68
1st DOWN Forecast2.06
2nd DOWN Forecast0.78
3rd DOWN Forecast-0.49
4th DOWN Forecast-2.55
 
ORMP Forecast2024
4th UP Forecast30.83
3rd UP Forecast22.18
2nd UP Forecast16.84
1st UP Forecast11.49
1st DOWN Forecast-3.75
2nd DOWN Forecast-9.1
3rd DOWN Forecast-14.44
4th DOWN Forecast-23.09
 
 
ORMP Other Details
Segment EQ
Market Capital 763756224.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ORMP Address
ORMP
 
ORMP Latest News
 
Your Comments and Response on Oramed Pharmaceuticals Inc
 
ORMP Business Profile
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service